Ashland Reaches New 52-Week High (ASH)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- Ashland (NYSE: ASH) hit a new 52-week high Thursday as it is currently trading at $86.84, above its previous 52-week high of $86.66 with 34,646 shares traded as of 10:07 a.m. ET. Average volume has been 709,500 shares over the past 30 days.

Ashland has a market cap of $6.72 billion and is part of the basic materials sector and chemicals industry. Shares are up 5.9% year to date as of the close of trading on Wednesday.

Ashland Inc. operates as a specialty chemicals company in the United States and internationally. It operates through four segments: Specialty Ingredients, Water Technologies, Performance Materials, and Consumer Markets. The company has a P/E ratio of 177.5, above the S&P 500 P/E ratio of 17.7.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates Ashland as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and poor profit margins. You can view the full Ashland Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE.
null

If you liked this article you might like

'Mad Money' Lightning Round: Southwestern Energy, UnitedHealth, Celgene and More

Jim Cramer's 'Mad Money' Recap: Don't Worry About a Little Market Detour

2 Specialty Chemical Stocks With Breakout Potential

3 Stocks Improving Performance Of The Chemicals Industry

Analysts' Actions -- Activision, Garmin, Match, Sirius and More